Tech

Dopl raises $6.3M to bring remote robotic ultrasounds to rural patients as it pursues FDA clearance

Published

on

Illustration of a patient receiving an ultrasound using Dopl’s remote technology as a medical assistant looks on. (Dopl Illustration)

Dopl Technologies announced $6.3 million in new funding to support the development and commercialization of a remotely operated robotic ultrasound system. The Bothell, Wash.-based startup has now raised more than $8 million.

Dopl is pursuing FDA clearance for its platform, which pairs off-the-shelf ultrasound probes with commercially available robots. The system facilitates communication between a remotely based ultrasound technician (or sonographer) and the robot, allowing the sonographer to conduct the exam with haptic feedback.

The platform also includes a video connection to allow conversations between the sonographer, patient and onsite health personnel.

The goal, said CEO Ryan James, is to target underserved and typically rural communities “to improve access to care and the time it takes for patients to get that care.”

Ryan James, CEO and co-founder of Dopl Technologies. (Dopl Photo)

While Dopl could eventually create remote interfaces for a variety of health services, ultrasound has widespread applications.

“People say that ultrasound is the new stethoscope,” James said. While perhaps best known for its use in obstetric exams during pregnancy, the diagnostic tool is also employed for cardiac and vascular exams and can be used to detect stroke, cancer, heart disease and other conditions.

Advertisement

The startup was co-founded by James, Chief Operating Officer Steve Seslar, and Chief Medical Officer Wayne Monsky, who began researching novel care delivery methods together at the University of Washington in 2017.

The system pulls together a suite of technologies including fine-motor robotic control, haptics, computer vision, AI, and advanced networking.

The new investment allows the company to hire staff to help it navigate the FDA approval process. Dopl is conducting clinical evaluations of its platform and aims to submit an application for FDA clearance next year.

Dopl currently provides in-person ultrasounds using its technology through traveling sonographer services. FDA clearance would allow it to perform remote robotic exams and scale its platform.

Advertisement

The startup has a letter of intent with a rural health care collaborative that includes 31 critical access hospitals in Washington and has partnerships across the nation, including on the East Coast.

The company also expects to take advantage of opportunities through the Rural Health Transformation Program, a $50 billion federal effort that will distribute funds in every state from fiscal years 2026 to 2030. The program is targeting innovations that expand access to care.

The seed round was led by SpringTide Ventures, which was joined by WRF Capital, Tacoma Venture Fund (pre-seed round lead), HeartX, Transform Health Ventures, Precursor Ventures, and additional early-stage institutional investors.

Dopl was a finalist for startup of the year at the 2026 GeekWire Awards.

Advertisement

There is competition in this market, including traditional ultrasound companies and startups. A notable rival is AdEchoTech, which launched in France in 2008 and has since received FDA clearance to sell in the U.S.

James said Dopl’s haptic technology sets it apart, allowing remote technicians”to actually feel the patient as they’re scanning.”

The remote robotic care delivery industry is rapidly growing, James said, and “represents the next wave of care delivery and shift in mindset in terms of how clinicians operate.”

Source link

Advertisement

You must be logged in to post a comment Login

Leave a Reply

Cancel reply

Trending

Exit mobile version